These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3032639)

  • 1. Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.
    Bertrand JM; Langhendries JP; Gras A; Battisti O
    Eur J Pediatr; 1987 Mar; 146(2):145-6. PubMed ID: 3032639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

  • 4. Digoxin-like immunoreactive substance in renal transplant patients.
    Schrader BJ; Maddux MS; Veremis SA; Mozes MF; Maturen A; Bauman JL
    J Clin Pharmacol; 1991 Dec; 31(12):1126-31. PubMed ID: 1662232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study into the nature and organ source of digoxin-like immunoreactive substance(s) in the perinatal period.
    Seccombe DW; Pudek MR; Humphries KH; Matthewson B; Taylor GP; Jacobson BE; Whitfield MP
    Biol Neonate; 1989; 56(3):136-46. PubMed ID: 2553137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-like immunoreactive substance in nonoliguric hyperkalemia of the premature infant.
    Mildenberger E; Oels K; Bauer K; Paul M; Versmold HT
    Biol Neonate; 2003; 83(3):182-7. PubMed ID: 12660435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin-like-immunoreactive substance: non-specific interference or a new hormone?
    Clerico A; Ghione S; Balzan S; Del Chicca MG
    J Nucl Med Allied Sci; 1984; 28(4):297-301. PubMed ID: 6100187
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between endogenous digoxin-like immunoreactivity and 86Rb uptake by erythrocytes in extracts of human plasma.
    Balzan S; Montali U; Genovesi-Ebert A; Biver P; Fantoni M; Ghione S
    Clin Sci (Lond); 1989 Oct; 77(4):375-81. PubMed ID: 2553327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic activity of digoxin-like immunoreactive substance extracted from cord blood.
    Ebara H; Suzuki S; Nagashima K; Kuroume T
    Life Sci; 1988; 42(3):303-9. PubMed ID: 2826960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin-like immunoreactive substance in urine of patients with mucocutaneous lymph node syndrome (MCLS).
    Tamura H; Shimoyama S; Sunaga Y; Sakaguchi M; Kuroume T
    Angiology; 1992 Oct; 43(10):856-65. PubMed ID: 1335703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous digoxin-like substance in the urine of newborns and children.
    Kovács L; Lichardus B; Benetínová J; Orbanová Z; Bircák J
    Bratisl Lek Listy; 1990 Jun; 91(6):423-32. PubMed ID: 2168233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal changes in a digoxin-like immunoreactive substance.
    Seccombe DW; Pudek MR; Whitfield MF; Jacobson BE; Wittmann BK; King JF
    Pediatr Res; 1984 Nov; 18(11):1097-9. PubMed ID: 6514436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-like immunoreactive substance and preterm labor.
    Ayhan A; Yarali H; Diker I; Urman B; Develioğlu O
    Gynecol Obstet Invest; 1990; 30(2):75-7. PubMed ID: 2245952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of a digitalis-like compound in the human fetus.
    Guédeney X; Chanez C; Scherrmann JM
    Biol Neonate; 1991; 59(3):133-8. PubMed ID: 1647221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.